Objectives
COVID-19 infection has been compared to seasonal influenza as an argument against non-pharmacological population based infection control measures known as “lockdowns”. Our study sought to compare disease severity measures for patients in Ireland hospitalised with COVID-19 against those hospitalised with seasonal influenza.
Study Design
Retrospective population-based cohort study.
Methods
COVID-19 hospital episodes and seasonal influenza hospital episodes were identified using relevant International Classification of Disease (ICD-10) codes in the Irish national hospitalisation dataset. Occurrence of key metrics of disease severity, length of stay, intensive care admission, ventilatory support, haemodialysis and in-hospital mortality were measured and compared between the two groups using odds ratios with 95% confidence intervals, stratified by age.
Results
Hospitalised COVID-19 episodes had a mean length of stay more than twice as long as hospitalised influenza episodes (17.7 days vs. 8.3 days). The likelihood of all measures of disease severity were greater in COVID-19 episodes, and the odds of in-hospital mortality were five-fold higher in this group compared with seasonal influenza episodes (OR 5.07, 95% C.I. 4.29-5.99, p<0.001). Greater likelihood of increased disease severity was observed for COVID-19 episodes in most age groups.
Conclusions
COVID-19 is a more severe illness than seasonal influenza in hospitalised cohorts. It is imperative that public health professionals ensure evidence-based advocacy is part of the response to COVID-19 to tackle a dangerous “infodemic” which can undermine public health control measures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.